B7-H3 Orchestrates Fibro-Immune Spatial Organisation in Pancreatic Cancer
In the authors' words
Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal cancers in the western world and is largely resistant to treatment. A major barrier to effective treatment is the highly desmoplastic and immunosuppressive tumour microenvironment, where the organisation of tumour, stromal and resident immune cells limit immune infiltration. B7-H3 (CD276) is an emerging immune checkpoint marker investigated in phase I and Ib/2 clinical trials in PDAC, yet its biological role within the tumour environment remains poorly understood. We performed an integrated multiscale spatial profiling study to map B7-H3 expression across regional and single-cell spatial contexts in treatment-naive resected human PDAC. Furthermore, we explored the B7-H3 landscape in the neoadjuvant setting. Our results demonstrate that B7-H3 is not simply overexpressed in cancer but may act as a spatial organiser of the PDAC microenvironment, associated with a transition from epithelial-intrinsic tumour architecture to fibro-inflammatory immune states that underpin immune suppression, aggressive disease and poor prognosis. This fibro-inflammatory state appears conserved within the neoadjuvant landscape.
Appeared: Thursday, November 19. bioRxiv. Preprint, not yet peer-reviewed.